Stryker Corp (SYK)

Industry Medical Devices


This stock can be held in an Investment ISA and an Investment Account
Sell

$353.01

Buy

$354.60

arrow-up$1.22 (+0.34%)

Prices updated at 15 Dec 2025, 13:53 EST
| Prices minimum 15 mins delay
|
Prices in USD

Stryker Corp is engaged in designing, manufacturing and marketing of medical equipment, instruments, and implantable devices. Its products include hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, and spinal devices.

Income statement

20232024
20,498m22,595m
13,058m14,440m
3,924m4,666m
19.1420.65
3,165m2,993m
4,952m5,716m
Sales, General and administrative7,111m7,685m
Interest expenses--
Provision for income taxes508m499m
Operating expenses9,134m9,774m
Income before taxes3,673m3,492m
Net income available to common shareholders3,165m2,993m
8.347.86
Net interest income--
Advertising and promotion--
Net investment income, net--
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)8.257.76
Free cash flow per share6.69938.3252
Book value/share47.10652.8291
Debt equity ratio0.5862960.590676

Balance sheet

20232024
Current assets12,518m14,847m
Current liabilities7,921m7,616m
Total capital29,494m32,822m
Total debt12,995m13,597m
Total equity18,593m20,634m
Total non current liabilities--
Loans10,901m12,188m
Total assets39,912m42,971m
Total liabilities--
Cash and cash equivalents2,971m3,652m
Common stock380m381m

Cash flow

20232024
Cash at beginning of period1,844m2,971m
Cash dividends paid-1,139m-1,219m
3,136m3,487m
Investments (gains) losses-962m-3,000m
2,971m3,652m
Net income--
3,711m4,242m
-575m-755m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.